Fig. 2.
Overall survival FIGO IIB-IV in months: OS in 307 patients with FIGO IIB–IV ovarian cancer was 53.6 months (95 % CI 41.6–65.5 months)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.